Severe Infections Caused by Pseudomonas Aeruginosa

Severe Infections Caused by Pseudomonas Aeruginosa PDF Author: Alan R. Hauser
Publisher: Springer Science & Business Media
ISBN: 1461504333
Category : Medical
Languages : en
Pages : 331

Get Book Here

Book Description
Severe Infections Caused by Pseudomonas aeruginosa emphasizes controversies worldwide in the diagnosis, treatment, prevention and pathogenesis of pseudomonas aeruginosa infections. By including both chapters written by European authors and chapters written by North American experts, the reader is ensured of receiving a broad spectrum of opinions on controversial topics. Special attention is paid to such topics as the diagnosis of hospital-acquired pneumonia caused by p. aeruginosa, scheduled antibiotic therapy for patients with cystic fibrosis, empiric therapy for febrile neurotropenic patients, combination vs. single agent antibiotic therapy for severely ill patients, and alternatives to conventional antibiotic therapies. This excellent overview of our current understanding of pseudomonas aeruginosa pathogenesis will prove useful to clinicians and microbiologists around the globe.

Severe Infections Caused by Pseudomonas Aeruginosa

Severe Infections Caused by Pseudomonas Aeruginosa PDF Author: Alan R. Hauser
Publisher: Springer Science & Business Media
ISBN: 1461504333
Category : Medical
Languages : en
Pages : 331

Get Book Here

Book Description
Severe Infections Caused by Pseudomonas aeruginosa emphasizes controversies worldwide in the diagnosis, treatment, prevention and pathogenesis of pseudomonas aeruginosa infections. By including both chapters written by European authors and chapters written by North American experts, the reader is ensured of receiving a broad spectrum of opinions on controversial topics. Special attention is paid to such topics as the diagnosis of hospital-acquired pneumonia caused by p. aeruginosa, scheduled antibiotic therapy for patients with cystic fibrosis, empiric therapy for febrile neurotropenic patients, combination vs. single agent antibiotic therapy for severely ill patients, and alternatives to conventional antibiotic therapies. This excellent overview of our current understanding of pseudomonas aeruginosa pathogenesis will prove useful to clinicians and microbiologists around the globe.

Pseudomonas aeruginosa infection in people with cystic fibrosis

Pseudomonas aeruginosa infection in people with cystic fibrosis PDF Author:
Publisher:
ISBN: 9780954053628
Category : Pseudomonas aeruginosa infections
Languages : en
Pages : 20

Get Book Here

Book Description


Pseudomonas Aeruginosa Chromosomal Beta-lactamase in Patients with Cystic Fibrosis and Chronic Lung Infection

Pseudomonas Aeruginosa Chromosomal Beta-lactamase in Patients with Cystic Fibrosis and Chronic Lung Infection PDF Author: Oana Ciofu
Publisher:
ISBN: 9781405123600
Category : Beta lactam antibiotics
Languages : en
Pages : 48

Get Book Here

Book Description


Pseudomonas Aeruginosa as an Opportunistic Pathogen

Pseudomonas Aeruginosa as an Opportunistic Pathogen PDF Author: Mario Campa
Publisher: Springer Science & Business Media
ISBN:
Category : Medical
Languages : en
Pages : 448

Get Book Here

Book Description
Provides balanced coverage of epidemiology, pathogenesis, clinical features, and control measures in 19 chapters contributed by authorities on specific aspects of P. aeruginosa research. The volume should prove useful to physicians and surgeons who have in their care patients infested, or at risk of

Pseudomonas Aeruginosa

Pseudomonas Aeruginosa PDF Author: L. D. Sabath
Publisher:
ISBN:
Category : Nosocomial infections
Languages : en
Pages : 280

Get Book Here

Book Description


Pseudomonas Aeruginosa

Pseudomonas Aeruginosa PDF Author: Beningo M. Penha Escudeiro
Publisher: Nova Science Publishers
ISBN: 9781622571987
Category : Pseudomonas aeruginosa infections
Languages : en
Pages : 0

Get Book Here

Book Description
Pseudomonas aeruginosa is a unique pathogen with a characteristic hospital epidemiology resulting in colonisation and major infectious complications. Institutions of infection control policies including guidelines on surveillance, infection control interventions and environmental decontamination are important preventive measures. In this book, the authors present current research on the symptoms of infection, antibiotic resistance and treatment of pseudomonas aeruginosa. Topics discussed include the mechanisms of antimicrobial resistance and antimicrobial treatment options; chronic pseudomonas aeruginosa infection in cystic fibrosis; and biofilm-forming ability and antimicrobial resistance of pseudomonas aeruginosa isolates of veterinary origin.

Cystic Fibrosis Pulmonary Infections: Lessons from Around the World

Cystic Fibrosis Pulmonary Infections: Lessons from Around the World PDF Author: Adolf Bauernfeind
Publisher: Birkhäuser
ISBN: 303487359X
Category : Medical
Languages : en
Pages : 337

Get Book Here

Book Description
Infection of the lower respiratory tract is a major determinant of the course of cystic fibrosis. Although numerous efforts have been made to elucidate the specific mechanisms predisposing the respiratory mucosa of cystic fibrosis patients to infection, so far no clinically relevant procedures for completely effective prevention or control of infection have resulted. Hence, in dealing with infections in cystic fibrosis, we continue to rely mainly on antimicrobials. Antiinfective measures are inseparably correlated with microbiology, and the quality of antiinfec tive therapy directly reflects the quality of microbial monitoring. Vali dated guidelines for microbiologic testing and antiinfective use need to be developed and made available to all health providers and their cystic fibrosis patients. Several years ago, the editors cochaired a symposium at the Interna tional Congress of Chemotherapy on the Global Perspectives of Micro biological and Clinical Infectious Diseases in Patients with Cystic Fibrosis. During this half-day symposium, the editors heard reports from several countries around the world with an alarming range of survival for patients with cystic fibrosis. This sent a dramatic message to us that the understanding of this disease, its diagnosis, management and prevention was different in various countries and that patients may be inconsistently served. That is how our journey began.

MUCOVISCIDOSE ET INFECTION A PSEUDOMONAS AERUGINOSA

MUCOVISCIDOSE ET INFECTION A PSEUDOMONAS AERUGINOSA PDF Author: GABRIEL.. KRISTOFIC
Publisher:
ISBN:
Category :
Languages : fr
Pages :

Get Book Here

Book Description


IgG Subclasses and Chronic Bacterial Infection

IgG Subclasses and Chronic Bacterial Infection PDF Author: Tacjana Pressler
Publisher:
ISBN: 9788716156495
Category : Pseudomonas aeruginosa infections
Languages : en
Pages : 41

Get Book Here

Book Description


Traitement de l'infection à Pseudomonas aeruginosa dans la mucoviscidose

Traitement de l'infection à Pseudomonas aeruginosa dans la mucoviscidose PDF Author: Camille Gros
Publisher:
ISBN:
Category :
Languages : fr
Pages : 324

Get Book Here

Book Description
La mucoviscidose est une maladie génétique mortelle due à une viscosité anormale des sécrétions muqueuses par suite d'une mutation sur le gène CFTR qui code pour la protéine CFTR, canal chlorure exprimé à la surface des cellules épithéliales. L'atteinte est multiviscérale avec une prédominance respiratoire. Pseudomonas aeruginosa, bactérie opportuniste, est responsable d'une infection respiratoire chez la grande majorité des patients. Cette infection évolue vers la chronicité et conduit généralement au décès. Les antibiotiques par voie orale, intraveineuse ou inhalée ont permis d'augmenter la durée de vie des patients. Néanmoins, dès lors que l'infection chronique est installée, l'éradication de la bactérie est impossible et les médecins sont de plus en plus confrontés aux résistances bactériennes. De nouveaux traitements antibactériens sont indispensables pour améliorer la prise en charge. Les traitements actuellement en développement sont essentiellement des formes inhalées d'antibiotiques largement utilisés qui amélioreront la qualité de vie des patients, mais ne permettront pas d'éliminer la bactérie. D'autres traitements plus innovants, comme une solution d'anticorps polyclonaux dirigés contre Pseudomonas aeruginosa, n'en sont qu'aux premiers stades de développement mais pourraient apporter un réel progrès thérapeutique en raison de leurs mécanismes d'action nouveaux.